Insiders / Lorrain Daniel S.

Lorrain Daniel S.

CIK 1861550personinsider
Companies
1
First seen
Jan 6, 2026
Last activity
Mar 2, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Contineum Therapeutics, Inc. · CTNMExecutive151,882160,72219

All securities held

2 positions · latest reported per filing
CompanySecuritySharesAs of
Contineum Therapeutics, Inc.Class A Common Stock151,882Mar 2, 2026
Contineum Therapeutics, Inc.Stock Option (right to buy)Derivative73,806Feb 25, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Feb 24, 2026SellCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$68.9K-4K
-2.68%
156,052
0.41% of shares
low
Mar 2, 2026SellCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$62.6K-4K
-2.67%
151,882
0.40% of shares
low
Feb 25, 2026SellCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$61.2K-4K
-2.39%
156,052
0.41% of shares
low
Feb 3, 2026SellCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$44.5K-3K
-1.87%
157,222
0.42% of shares
low
Jan 5, 2026SellCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$38.0K-4K
-2.23%
160,722
0.43% of shares
low
Feb 3, 2026SellCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$17.8K-1K
-0.74%
156,052
0.41% of shares
low
Feb 11, 2026SellCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$6.4K-400
-0.26%
156,052
0.41% of shares
low
Jan 5, 2026SellCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$5.6K-500
-0.31%
160,222
0.43% of shares
low
Feb 24, 2026ExerciseCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$4.3K+4K
+2.76%
160,352
0.43% of shares
low
Feb 25, 2026ExerciseCTNM
Contineum Therapeutics, Inc.
Class A Common Stock
$3.9K+4K
+2.45%
159,876
0.42% of shares
low